glp-1 compounding news november 2025 FDA unleashes warning letters to firms selling compounded GLP-1s Novo Nordisk Drops Hims &

It never guarantees safety

Wang L., et al

[1] These are meaningful cosmetic endpoints, and they map logically onto the mechanism: more collagen and glycosaminoglycan synthesis, better-organized remodeling, and reduced oxidative and inflammatory burden should, in principle, translate into firmer, smoother, more resilient skin

If youre denied, the exact wording matters: criteria not met usually means you can appeal with documentation, while excluded from coverage may require an exception or employer benefits route

At lower doses, patients often experience fewer gastrointestinal symptoms such as nausea or vomiting, which can occur when GLP-1s are escalated too quickly